Potential delay in the diagnosis of vulvar cancer and associated risk factors in women treated in German gynecological practices
- PMID: 29492231
- PMCID: PMC5823582
- DOI: 10.18632/oncotarget.23848
Potential delay in the diagnosis of vulvar cancer and associated risk factors in women treated in German gynecological practices
Abstract
The goal of this study was to estimate a potential delay in the diagnosis of vulvar cancer and identify associated risk factors in women treated in gynecological practices in Germany. The current study sample included 1,652 women from 218 gynecological practices who received an initial diagnosis of vulvar cancer (ICD 10: C51) between January 2000 and December 2015 (index date). After applying several exclusion criteria, 505 non-cancer controls were matched (1:1) to 505 vulvar cancer cases based on age, health insurance status, and index date. The primary outcome was the delay in vulvar cancer diagnosis in women who had received an initial diagnosis of diseases of Bartholin's gland, inflammation of vagina and vulva, or other specified noninflammatory disorders of vulva, including atrophy, hypertrophy, and cyst. A logistic regression model was used to estimate the association between vulvar cancer and pre-defined diagnoses. The mean age was 60.8 years (SD = 15.6 years), and 4.8% of women had private health insurance coverage. Inflammation of vagina and vulva was diagnosed 328 days (SD = 95 days) prior to the detection of vulvar cancer. This delay was 186 days (SD = 196 days) in patients affected by diseases of Bartholin's gland and 300 days (SD = 116 days) in those with other specified noninflammatory disorders of vulva including atrophy, hypertrophy, and cyst. The risk of vulvar cancer was positively associated with inflammation of vagina and vulva (OR = 2.28) and other specified noninflammatory disorders of vulva (OR = 5.39). The mean potential delay of vulvar cancer diagnosis ranged from 186 to 328 days.
Keywords: delay; risk factors; vulva infection; vulva inflammation; vulvar cancer.
Conflict of interest statement
CONFLICTS OF INTEREST All authors declare that they have no conflicts of interest.
Figures
References
-
- Hacker NF, Eifel PJ, van der Velden J. Cancer of the vulva. Int J Gynaecol Obstet. 2015;131 Suppl 2:S76–83. https://doi.org/10.1016/j.ijgo.2015.06.002. - DOI - PubMed
-
- Institut für Krebsepidemiologie Aktuelle Zahlen zum Vulvakarzinom in Deutschland. 2014 [cited 2017 Jun 18]. Available 2017 Jun 18, from http://vulvakarzinom-shg.de/docs/Epidemiologie_VulvaKarzinom_2014.pdf.
-
- Robert Koch-Institut Neue Daten zu Krebs in Deutschland. 2015 [cited 2017 Jun 18]. Available 2017 Jun 18, from https://www.rki.de/DE/Content/Service/Presse/Pressemitteilungen/2015/11_....
-
- Rosén C, Malmström H. Invasive cancer of the vulva. Gynecol Oncol. 1997;65:213–7. https://doi.org/10.1006/gyno.1997.4662. - DOI - PubMed
-
- Jones RW, Joura EA. Analyzing prior clinical events at presentation in 102 women with vulvar carcinoma. Evidence of diagnostic delays. J Reprod Med. 1999;44:766–8. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources